...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Optical and quantum electronics >Clinical experience with Bausch & Lomb Technolas-217 excimer laser
【24h】

Clinical experience with Bausch & Lomb Technolas-217 excimer laser

机译：Bausch＆Lomb Technolas-217准分子激光的临床经验

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

We retrospectively followed up 177 eyes of 90 myopic patients who had received laser in situ keratomileusis (LASIK) using Bausch & Lomb Technolas-217 laser. All patients underwent comprehensive preoperative ophthalmologic examinations. Results were analyzed from examinations performed at 1 week, 1, 3 and 6 months intervals after surgery. The preoperative mean spherical equivalent refraction was -6.19 D. The 6-month follow-up rate was 86%. The mean postoperative spherical equivalent refraction was -0.28 D. Thirty-two percent of eyes achieved 1.5 or better uncorrected visual acuity (UCVA), 86% of eyes achieved 1.2 or better UCVA and 98% achieved 1.0 or better UCVA. The safety, efficacy, predictability and the visual results were proved to be excellent.
机译：我们回顾性随访了使用博士伦（Lausch＆Lomb Technolas-217）激光接受原位角膜磨镶术（LASIK）的90名近视患者的177眼。所有患者均接受了术前全面的眼科检查。从手术后1周，1、3和6个月的间隔中进行的检查分析结果。术前平均等效球镜屈光度为-6.19D。6个月的随访率为86％。术后平均等效球镜屈光度为-0.28D。32％的眼睛获得1.5或更高的未矫正视力（UCVA），86％的眼睛获得UCVA达到1.2或更高，98％的眼睛获得1.0或更高的UCVA。安全性，有效性，可预测性和视觉效果均被证明是极好的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号